Ozzy Osbourne will reunite with all of the original members of Black Sabbath for the first time in 20 years, in a gig that ...

Marc Cohn is sharing his Parkinson’s disease diagnosis publicly for the first time. The “Walking in Memphis” artist, 65, took to Instagram on Thursday, Jan. 30 to share a health update with his fans ...

Newronika, the developer of groundbreaking adaptive deep brain stimulation technology, is proud to announce the receipt of an ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

A compound that showed early promise in the treatment of Parkinson's disease in fruit flies has also shown neuroprotective ...

Marc Cohn, a Cleveland native and the Grammy Award-winning singer of “Walking in Memphis,” revealed he was diagnosed with Parkinson’s disease five years ago. Cohn, 65, shared the news of his diagnosis ...

JOTROL is designed to overcome the historical challenges of resveratrol by significantly enhancing bioavailability while minimizing gastrointestinal side effects. The upcoming Phase 2a trial will ...

In his testimony this week, Kennedy claimed that infectious diseases receive far more federal funding than chronic diseases.

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...

Earleen Fisher, an editor and writer whose career across five decades with The Associated Press gave her a front-row seat to ...

Advanced AI genetics models reveal key genetic markers and potential drug repurposing for Parkinson's disease, accelerating the search for new treatments.